Linked Life Data

16849522

Source:http://linkedlifedata.com/resource/pubmed/id/16849522

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16849522rdf:typepubmed:Citationlld:pubmed
pubmed-article:16849522lifeskim:mentionsumls-concept:C0024660lld:lifeskim
pubmed-article:16849522lifeskim:mentionsumls-concept:C0040711lld:lifeskim
pubmed-article:16849522lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:16849522lifeskim:mentionsumls-concept:C0812228lld:lifeskim
pubmed-article:16849522lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:16849522lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:16849522lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:16849522lifeskim:mentionsumls-concept:C1521840lld:lifeskim
pubmed-article:16849522lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:16849522lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:16849522pubmed:issue7lld:pubmed
pubmed-article:16849522pubmed:dateCreated2006-7-19lld:pubmed
pubmed-article:16849522pubmed:abstractTextThe phosphoinositide 3-kinase (PI3K)/Akt pathway is commonly activated in cancer; therefore, we investigated its role in hypoxia-inducible factor-1alpha (HIF-1alpha) regulation. Inhibition of PI3K in U87MG glioblastoma cells, which have activated PI3K/Akt activity secondary to phosphatase and tensin homologue deleted on chromosome 10 (PTEN) mutation, with LY294002 blunted the induction of HIF-1alpha protein and its targets vascular endothelial growth factor and glut1 mRNA in response to hypoxia. Introduction of wild-type PTEN into these cells also blunted HIF-1alpha induction in response to hypoxia and decreased HIF-1alpha accumulation in the presence of the proteasomal inhibitor MG132. Akt small interfering RNA (siRNA) also decreased HIF-1alpha induction under hypoxia and its accumulation in normoxia in the presence of dimethyloxallyl glycine, a prolyl hydroxylase inhibitor that prevents HIF-1alpha degradation. Metabolic labeling studies showed that Akt siRNA decreased HIF-1alpha translation in normoxia in the presence of dimethyloxallyl glycine and in hypoxia. Inhibition of mammalian target of rapamycin (mTOR) with rapamycin (10-100 nmol/L) had no significant effect on HIF-1alpha induction in a variety of cell lines, a finding that was confirmed using mTOR siRNA. Furthermore, neither mTOR siRNA nor rapamycin decreased HIF-1alpha translation as determined by metabolic labeling studies. Therefore, our results indicate that Akt can augment HIF-1alpha expression by increasing its translation under both normoxic and hypoxic conditions; however, the pathway we are investigating seems to be rapamycin insensitive and mTOR independent. These observations, which were made on cells grown in standard tissue culture medium (10% serum), were confirmed in PC3 prostate carcinoma cells. We did find that rapamycin could decrease HIF-1alpha expression when cells were cultured in low serum, but this seems to represent a different pathway.lld:pubmed
pubmed-article:16849522pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16849522pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16849522pubmed:languageenglld:pubmed
pubmed-article:16849522pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16849522pubmed:citationSubsetIMlld:pubmed
pubmed-article:16849522pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16849522pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16849522pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16849522pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16849522pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16849522pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16849522pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16849522pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16849522pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16849522pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16849522pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16849522pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16849522pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16849522pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16849522pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16849522pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16849522pubmed:statusMEDLINElld:pubmed
pubmed-article:16849522pubmed:monthJullld:pubmed
pubmed-article:16849522pubmed:issn1541-7786lld:pubmed
pubmed-article:16849522pubmed:authorpubmed-author:KaoGary DGDlld:pubmed
pubmed-article:16849522pubmed:authorpubmed-author:BernhardEricElld:pubmed
pubmed-article:16849522pubmed:authorpubmed-author:PoreNabenduNlld:pubmed
pubmed-article:16849522pubmed:authorpubmed-author:MaityAmitAlld:pubmed
pubmed-article:16849522pubmed:authorpubmed-author:JiangZibinZlld:pubmed
pubmed-article:16849522pubmed:authorpubmed-author:ShuHui-KuoHKlld:pubmed
pubmed-article:16849522pubmed:issnTypePrintlld:pubmed
pubmed-article:16849522pubmed:volume4lld:pubmed
pubmed-article:16849522pubmed:ownerNLMlld:pubmed
pubmed-article:16849522pubmed:authorsCompleteYlld:pubmed
pubmed-article:16849522pubmed:pagination471-9lld:pubmed
pubmed-article:16849522pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:16849522pubmed:meshHeadingpubmed-meshheading:16849522...lld:pubmed
pubmed-article:16849522pubmed:meshHeadingpubmed-meshheading:16849522...lld:pubmed
pubmed-article:16849522pubmed:meshHeadingpubmed-meshheading:16849522...lld:pubmed
pubmed-article:16849522pubmed:meshHeadingpubmed-meshheading:16849522...lld:pubmed
pubmed-article:16849522pubmed:meshHeadingpubmed-meshheading:16849522...lld:pubmed
pubmed-article:16849522pubmed:meshHeadingpubmed-meshheading:16849522...lld:pubmed
pubmed-article:16849522pubmed:meshHeadingpubmed-meshheading:16849522...lld:pubmed
pubmed-article:16849522pubmed:meshHeadingpubmed-meshheading:16849522...lld:pubmed
pubmed-article:16849522pubmed:meshHeadingpubmed-meshheading:16849522...lld:pubmed
pubmed-article:16849522pubmed:meshHeadingpubmed-meshheading:16849522...lld:pubmed
pubmed-article:16849522pubmed:meshHeadingpubmed-meshheading:16849522...lld:pubmed
pubmed-article:16849522pubmed:meshHeadingpubmed-meshheading:16849522...lld:pubmed
pubmed-article:16849522pubmed:meshHeadingpubmed-meshheading:16849522...lld:pubmed
pubmed-article:16849522pubmed:meshHeadingpubmed-meshheading:16849522...lld:pubmed
pubmed-article:16849522pubmed:meshHeadingpubmed-meshheading:16849522...lld:pubmed
pubmed-article:16849522pubmed:meshHeadingpubmed-meshheading:16849522...lld:pubmed
pubmed-article:16849522pubmed:meshHeadingpubmed-meshheading:16849522...lld:pubmed
pubmed-article:16849522pubmed:meshHeadingpubmed-meshheading:16849522...lld:pubmed
pubmed-article:16849522pubmed:year2006lld:pubmed
pubmed-article:16849522pubmed:articleTitleAkt1 activation can augment hypoxia-inducible factor-1alpha expression by increasing protein translation through a mammalian target of rapamycin-independent pathway.lld:pubmed
pubmed-article:16849522pubmed:affiliationDepartment of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia, 19104, USA.lld:pubmed
pubmed-article:16849522pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16849522pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:16849522pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
entrez-gene:207entrezgene:pubmedpubmed-article:16849522lld:entrezgene
entrez-gene:2475entrezgene:pubmedpubmed-article:16849522lld:entrezgene
entrez-gene:3091entrezgene:pubmedpubmed-article:16849522lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16849522lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16849522lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16849522lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16849522lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16849522lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16849522lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16849522lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16849522lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16849522lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16849522lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16849522lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16849522lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16849522lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16849522lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16849522lld:pubmed